The most common ones you will encounter are: 1 mg/mL - A lower concentration, often used for initial titration doses
And the weight is coming off steadily
Yes and No Semaglutide is the active ingredient, and Ozempic is a brand name that contains it, but saying same drug as shorthand is misleading because dosing, regulatory intent, formulation, and how clinicians titrate or monitor treatment all affect outcomes
Neural indicators of food cue reactivity, regulation, and valuation and their associations with body composition and daily eating behavior
I believe the side effects profile for management of diabetes is not the same as for management of obesity.
The bottom line on side effects: Retatrutide is not dramatically riskier for most people, but it is not a simple lateral move